BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Meijer LL, Strijker M, de Bakker JK, Toennaer JG, Zonderhuis BM, van der Vliet HJ, Wilmink H, Verheij J, Daams F, Busch OR, van Grieken NC, Besselink MG, Kazemier G. Clinical outcomes of patients with duodenal adenocarcinoma and intestinal-type papilla of Vater adenocarcinoma. World J Gastrointest Oncol 2020; 12(3): 347-357 [PMID: 32206184 DOI: 10.4251/wjgo.v12.i3.347]
URL: https://www.wjgnet.com/1948-5204/full/v12/i3/347.htm
Number Citing Articles
1
Yuanxiang Lu, Wensen Li, Ge Liu, Yongbo Yang, Erwei Xiao, Senmao Mu, Yuqi Guo, Deyu Li, Guoyi Yan. Identification of critical pathways and potential therapeutic targets in poorly differentiated duodenal papilla adenocarcinomaCancer Cell International 2021; 21(1) doi: 10.1186/s12935-020-01709-7
2
Ellery Altshuler, Raymond Richhart, William King, Mahmoud Aryan, Akash Mathavan, Akshay Mathavan, Keegan Hones, Daniel Leech, Logan Pucci, Joshua Riklan, Pat Haley, Ilyas Sahin, Brian Ramnaraign, Sherise Rogers, Ibrahim Nassour, Steven Hughes, Thomas J. George, Jesus Fabregas. Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort studyOncotarget 2023; 14(1): 351 doi: 10.18632/oncotarget.28406
3
Jacob de Bakker, Dirkje Sommeijer, Marc Besselink, Geert Kazemier, Nicole van Grieken. The use of histopathological subtyping in patients with ampullary cancer: a nationwide analysisWorld Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02873-y